» Articles » PMID: 37273129

Profound Metabolic Acidosis in Association with Sodium Thiosulfate Therapy in a Patient with Calcific Uremic Arteriolopathy: a Case Report and Literature Review

Overview
Journal CEN Case Rep
Specialty Nephrology
Date 2023 Jun 5
PMID 37273129
Authors
Affiliations
Soon will be listed here.
Abstract

Calciphylaxis, also known as Calcific uremic arteriolopathy (CUA), is a serious disorder that presents with skin necrosis due to calcification of dermal and subcutaneous adipose tissue capillaries and arterioles. The condition occurs primarily in patients with end-stage renal disease (ESRD) on dialysis, and it carries high morbidity and mortality, primarily due to sepsis, with an estimated six-month survival of approximately 50%. Although there are no high-quality studies to guide the optimal treatment approach for patients with calciphylaxis, many retrospective studies and case series support treatment with sodium thiosulfate (STS). Despite the frequent use of STS as an off-label treatment, data regarding its safety and efficacy are limited. STS has generally been considered a safe drug with mild side effects. However, severe metabolic acidosis associated with STS is a rare and life-threatening complication of STS treatment and is often unpredictable. Herein, we report a 64-year-old female with ESRD on peritoneal dialysis (PD) who presented with a profound high anion gap metabolic acidosis and severe hyperkalemia while on STS treatment for CUA. No other etiology for her severe metabolic acidosis other than STS was identified. ESRD patients receiving STS should be monitored closely for this side effect. Dose reduction, increasing the duration of infusion, or even discontinuing STS treatment should be considered if severe metabolic acidosis develops.

References
1.
Vanparys J, Sprangers B, Sagaert X, Kuypers D . Chronic wounds in a kidney transplant recipient with moderate renal impairment. Acta Clin Belg. 2013; 68(2):128-31. DOI: 10.2143/ACB.3191. View

2.
Selk N, Rodby R . Unexpectedly severe metabolic acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy. Semin Dial. 2011; 24(1):85-8. DOI: 10.1111/j.1525-139X.2011.00848.x. View

3.
Zitt E, Konig M, Vychytil A, Auinger M, Wallner M, Lingenhel G . Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant. 2013; 28(5):1232-40. DOI: 10.1093/ndt/gfs548. View

4.
Okonkwo O, Batwara R, Granja I, Asplin J, Goldfarb D . A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria. PLoS One. 2013; 8(4):e60380. PMC: 3620159. DOI: 10.1371/journal.pone.0060380. View

5.
Brucculeri M, Cheigh J, Bauer G, Serur D . Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial. 2005; 18(5):431-4. DOI: 10.1111/j.1525-139X.2005.00082.x. View